Pacer Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-960
| Closed | -$45.8K | – | 2597 |
|
|
2024
Q2 | $45.8K | Sell |
960
-11
| -1% | -$524 | ﹤0.01% | 3193 |
|
|
2024
Q1 | $42.1K | Buy |
+971
| New | +$42.1K | ﹤0.01% | 3238 |
|
|
2021
Q2 | – | Sell |
-1,471
| Closed | -$66K | – | 1476 |
|
|
2021
Q1 | $66K | Sell |
1,471
-1,410
| -49% | -$63.3K | ﹤0.01% | 1398 |
|
|
2020
Q4 | $163K | Buy |
2,881
+1,080
| +60% | +$61.1K | ﹤0.01% | 1267 |
|
|
2020
Q3 | $85K | Buy |
+1,801
| New | +$85K | ﹤0.01% | 1272 |
|
|
2019
Q3 | – | Sell |
-20,333
| Closed | -$1.31M | – | 1187 |
|
|
2019
Q2 | $1.31M | Buy |
+20,333
| New | +$1.31M | 0.03% | 699 |
|
|
2019
Q1 | – | Sell |
-12,106
| Closed | -$654K | – | 754 |
|
|
2018
Q4 | $654K | Buy |
12,106
+6,187
| +105% | +$334K | 0.02% | 118 |
|
|
2018
Q3 | $305K | Buy |
+5,919
| New | +$305K | 0.01% | 949 |
|
|
2018
Q1 | – | Sell |
-1,982
| Closed | -$100K | – | 1085 |
|
|
2017
Q4 | $100K | Sell |
1,982
-13,979
| -88% | -$705K | 0.01% | 960 |
|
|
2017
Q3 | $809K | Buy |
15,961
+2,002
| +14% | +$101K | 0.07% | 403 |
|
|
2017
Q2 | $710K | Buy |
13,959
+922
| +7% | +$46.9K | 0.07% | 409 |
|
|
2017
Q1 | $524K | Buy |
13,037
+2,085
| +19% | +$83.8K | 0.06% | 462 |
|
|
2016
Q4 | $524K | Buy |
10,952
+605
| +6% | +$28.9K | 0.07% | 376 |
|
|
2016
Q3 | $379K | Buy |
10,347
+710
| +7% | +$26K | 0.06% | 484 |
|
|
2016
Q2 | $225K | Buy |
9,637
+8,049
| +507% | +$188K | 0.04% | 731 |
|
|
2016
Q1 | $64K | Buy |
1,588
+79
| +5% | +$3.18K | 0.01% | 746 |
|
|
2015
Q4 | $93K | Buy |
+1,509
| New | +$93K | 0.02% | 623 |
|